Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
Completed · Phase 2
Conditions studied: Cervical Cancer, Vaginal Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients with advanced, refractory, or recurrent cervical or vaginal cancer.
Key facts
- Study ID
- NCT00002562
- Run by
- Gynecologic Oncology Group
- People needed
- 25
- Starts
- 1994-03-01
- Expected to finish
- 2004-08-01
- Last updated by the study team
- 2013-06-20
Who can join
Age: any. Sex: female. Healthy volunteers: not accepted.
Where it is running
- University of Alabama Comprehensive Cancer Center — Birmingham, Alabama, United States
- USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
- Women's Cancer Center — Palo Alto, California, United States
- Stanford University Medical Center — Stanford, California, United States
- University of Colorado Cancer Center — Denver, Colorado, United States
- Vincent T. Lombardi Cancer Research Center, Georgetown University — Washington D.C., District of Columbia, United States
- Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
- H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
- Emory University Hospital - Atlanta — Atlanta, Georgia, United States
- MBCCOP - Hawaii — Honolulu, Hawaii, United States
- Rush-Presbyterian-St. Luke's Medical Center — Chicago, Illinois, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- Indiana University Cancer Center — Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- Albert B. Chandler Medical Center, University of Kentucky — Lexington, Kentucky, United States
- Johns Hopkins Oncology Center — Baltimore, Maryland, United States
- University of Massachusetts Memorial Medical Center — Worcester, Massachusetts, United States
- CCOP - Ann Arbor Regional — Ann Arbor, Michigan, United States
- Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
- University of Minnesota Cancer Center — Minneapolis, Minnesota, United States
- University of Mississippi Medical Center — Jackson, Mississippi, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Cooper Hospital/University Medical Center — Camden, New Jersey, United States
- Cancer Center of Albany Medical Center — Albany, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.